前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里




查看所有供应商和价格请点击:

27262-47-1生产厂家

27262-47-1价格

27262-47-1

27262-47-1结构式
27262-47-1结构式
  • 常用中文名:左布比卡因
  • 常用英文名:Levobupivacaine
  • CAS号:27262-47-1
  • 分子式:C18H28N2O
  • 分子量:288.428
  • 相关类别: 信号通路 细胞凋亡 Ferroptosis
  • 发布时间:2018-02-23 08:00:00
  • 更新时间:2024-01-03 12:13:33
  • 左旋布比卡因((S)-(-)-布比卡因)是一种长效酰胺类局部麻醉剂。左旋布比卡因通过可逆阻断神经元钠通道发挥麻醉和镇痛作用。左布比卡因可抑制心血管和其他组织中的脉冲传递和传导,具有一定的心脏和中枢神经系统毒性。左布比卡因在体内由肝细胞色素P450(CYP450)酶代谢。左旋布比卡因还可通过miR-489-3p/SLC7A11信号在胃癌中诱导铁下垂[1][2][3]。

化源商城直购

中文名 左布比卡因
英文名 levobupivacaine
中文别名 1-丁基-N-(2,6-二甲基苯基)-哌啶-2-甲酰胺
LEVOBUPIVACAINE 左布比卡因
左旋布比卡因
左布比咔因
英文别名 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-
(2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
L-(-)-Bupivacaine
2',6'-Pipecoloxylidide,1-butyl-,L-(-)
1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide
(-)-Bupivacaine
Levobupivacaine
1-butyl-piperidine-2-carboxylic acid-(2,6-dimethyl-anilide)
(S)-(-)-Bupivacaine
(S)-Bupivacaine
(2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
描述 左旋布比卡因((S)-(-)-布比卡因)是一种长效酰胺类局部麻醉剂。左旋布比卡因通过可逆阻断神经元钠通道发挥麻醉和镇痛作用。左布比卡因可抑制心血管和其他组织中的脉冲传递和传导,具有一定的心脏和中枢神经系统毒性。左布比卡因在体内由肝细胞色素P450(CYP450)酶代谢。左旋布比卡因还可通过miR-489-3p/SLC7A11信号在胃癌中诱导铁下垂[1][2][3]。
相关类别
靶点

Sodium channels, Ferroptosis[1][2]

体外研究 左旋布比卡因(0-4 mM;24小时)不影响GES-1细胞的存活率,但抑制HGC27和SGC7901细胞的存活[2]。左旋布比卡因(2mM;24、48或72小时)增强Erastin诱导的对HGC27和SGC7901细胞活性的抑制作用;诱导Fe2+、铁和脂质ROS的水平[2]。左旋布比卡因(2mM;24h)增强HGC27和SGC7901细胞中miR-489-3p的表达,增加Fe2+和铁的水平[2]。细胞活力测定[2]细胞系:GES-1、HGC27和SGC790浓度:0、0.5、1、2和4 mM孵育时间:24 h结果:不影响正常胃上皮GES-2细胞系的活力,但以剂量依赖性方式抑制HGC27与SGC7901细胞的活力。细胞存活率测定[2]细胞系:HGC27和SGC7901(与5μM erastin孵育)浓度:2mM孵育时间:24、48或72小时结果:erastin对HGC27及SGC791细胞存活率的抑制作用增强;诱导Fe2+、铁和脂质ROS的水平。RT-PCR[2]细胞系:HGC27和SGC7901(与5μM erastin孵育)浓度:2mM孵育时间:24h结果:增强了HGC27细胞和SGC79 01细胞中miR-489-3p的表达,增加了Fe2+和铁的水平。
体内研究 左旋布比卡因(40μmol/kg;IP;每天一次,持续25天)显著抑制SGC7901细胞生长,并增强脂质ROS的积累[2]。左旋布比卡因(5或36 mg/kg;IP;单剂量)增加部分癫痫发作的潜伏期,并在低剂量下防止全身性癫痫发作的发生;降低N-甲基-d-天冬氨酸(NMDA)诱导癫痫发作的潜伏期,并在高剂量下增加癫痫发作的严重程度[3]。动物模型:CD1小鼠(30-35g;通过注射NMDA诱导癫痫发作)[3]剂量:5或36mg/kg给药:IP;单剂量结果:5mg/kg增加了部分癫痫发作的潜伏期,并防止了全身性癫痫发作的发生;降低NMDA诱发癫痫的潜伏期,并增加36mg/kg时的癫痫严重程度。动物模型:SCID裸鼠(6-8周;皮下注射5×106 SGC7901细胞)[2]剂量:40μmol/kg给药:IP;结果:显著抑制SGC7901细胞生长,增强脂质ROS积累。
参考文献

[1]. Sanford M, et al. Levobupivacaine: a review of its use in regional anaesthesia and pain management. Drugs. 2010 Apr 16;70(6):761-91.

[2]. Mao SH, et al. Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer. Front Pharmacol. 2021 Jun 9;12:681338.

[3]. Marganella C, et al. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice. Eur J Pharmacol. 2005 Aug 22;518(2-3):111-5.

密度 1.0±0.1 g/cm3
沸点 423.4±45.0 °C at 760 mmHg
熔点 254ºC (dec.)(lit.)
分子式 C18H28N2O
分子量 288.428
闪点 209.9±28.7 °C
精确质量 288.220154
PSA 32.34000
LogP 3.64
外观性状 白色固体
蒸汽压 0.0±1.0 mmHg at 25°C
折射率 1.547
储存条件 库房通风低温干燥,与食品原料类分开存放

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TK6090000
CHEMICAL NAME :
2',6'-Pipecoloxylidide, 1-butyl-, L-(-)-
CAS REGISTRY NUMBER :
27262-47-1
LAST UPDATED :
199112
DATA ITEMS CITED :
7
MOLECULAR FORMULA :
C18-H28-N2-O
MOLECULAR WEIGHT :
288.48
WISWESSER LINE NOTATION :
T6NTJ A4 BVMR B1 F1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
52 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 31,273,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7200 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 31,273,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 31,273,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
9600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 31,273,1972
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
9700 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 31,273,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>120 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,78,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intratracheal
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
14 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,78,1976

危害码 (欧洲) Xn: Harmful;T+: Very toxic;
危险品运输编码 UN 2811 6
海关编码 2933399090
海关编码 2933399090
中文概述 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%